LFCR

SEC source: 0001376960-26-000002 · wk-form4_1780692392.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,967

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

SEC source: 0001017043-26-000002 · wk-form4_1780692442.xml · nonDerivative · entry 1

OBUS NELSON · CIK 0001017043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,100

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

SEC source: 0001336601-26-000004 · wk-form4_1780692374.xml · nonDerivative · entry 1

Schechter Joshua · CIK 0001336601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,080

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

SEC source: 0001649903-26-000002 · wk-form4_1780692359.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,967

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

SEC source: 0001800145-26-000002 · wk-form4_1780692316.xml · nonDerivative · entry 1

Antunes Humberto Calheiros · CIK 0001800145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,967

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

SEC source: 0002034858-26-000002 · wk-form4_1780692301.xml · nonDerivative · entry 1

Johnson Paul Harold · CIK 0002034858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,967

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

SEC source: 0001269294-26-000002 · wk-form4_1780692247.xml · nonDerivative · entry 1

HOUDE LOVAS KATRINA · CIK 0001269294 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,319

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

SEC source: 0000921895-26-001575 · form409050032_06082026.xml · nonDerivative · entry 1

Kiper Christopher S · CIK 0001432744 · Director · 10% owner

Legion Partners Asset Management, LLC · CIK 0001560207 · Director · 10% owner

Legion Partners, L.P. I · CIK 0001595909 · Director · 10% owner

Legion Partners, L.P. II · CIK 0001618783 · Director · 10% owner

Legion Partners, LLC · CIK 0001682390 · Director · 10% owner

Legion Partners Holdings, LLC · CIK 0001682389 · Director · 10% owner

White Raymond T. · CIK 0001682494 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,482

F1 · security: This Form 4 is filed jointly by Legion Partners, L.P. I ("Legion Partners I"), Legion Partners, L.P. II ("Legion Partners II"), Legion Partners, LLC ("General Partner"), Legion Partners Asset Management, LLC ("Legion Partners Asset Management"), Legion Partners Holdings, LLC ("Legion Partners Holdings"), Christopher S. Kiper and Raymond White (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that owns more than 10% of Lifecore Biomedical, Inc.'s (the "Issuer") outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F4 · kind: These securities are RSUs granted to Mr. Kiper, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Kiper holds these RSUs for the benefit of Legion Partners Asset Management. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions. As of the date hereof, 58,069 RSUs have vested.

F5 · kind: Mr. Kiper serves on the Board as a representative of Legion Partners Asset Management and its affiliates. Mr. Kiper does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position, except to the extent of his role as a Managing Director of Legion Partners Asset Management. Legion Partners Asset Management is entitled to receive all of the economic interest in securities granted to Mr. Kiper by the Issuer in respect of Mr. Kiper's Board position. Mr. Kiper disclaims beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Kiper had any economic interest in such securities except any indirect economic interest through Legion Partners Asset Management and its affiliates, entities in which Mr. Kiper has a controlling interest and investment control.

F6 · kind: The securities held by Mr. Kiper as described in footnotes (4) and (5) are securities in which Legion Partners Asset Management has all of the direct economic interest. Legion Partners Holdings is the sole member of Legion Partners Asset Management and each of Messrs. Kiper and White are Managing Directors of Legion Partners Asset Management. As a result of these relationships, Legion Partners Holdings and Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners Asset Management.

F2 · shares: The restricted stock units ("RSUs") convert into Common Stock of the Issuer on a 1 for 1 basis.

F3 · shares: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Issuer first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

F2 · price: The restricted stock units ("RSUs") convert into Common Stock of the Issuer on a 1 for 1 basis.

F3 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Issuer first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).

F4 · balance_after: These securities are RSUs granted to Mr. Kiper, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Kiper holds these RSUs for the benefit of Legion Partners Asset Management. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions. As of the date hereof, 58,069 RSUs have vested.

F5 · balance_after: Mr. Kiper serves on the Board as a representative of Legion Partners Asset Management and its affiliates. Mr. Kiper does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position, except to the extent of his role as a Managing Director of Legion Partners Asset Management. Legion Partners Asset Management is entitled to receive all of the economic interest in securities granted to Mr. Kiper by the Issuer in respect of Mr. Kiper's Board position. Mr. Kiper disclaims beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Kiper had any economic interest in such securities except any indirect economic interest through Legion Partners Asset Management and its affiliates, entities in which Mr. Kiper has a controlling interest and investment control.

F6 · balance_after: The securities held by Mr. Kiper as described in footnotes (4) and (5) are securities in which Legion Partners Asset Management has all of the direct economic interest. Legion Partners Holdings is the sole member of Legion Partners Asset Management and each of Messrs. Kiper and White are Managing Directors of Legion Partners Asset Management. As a result of these relationships, Legion Partners Holdings and Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners Asset Management.

F4 · ownership.direct: These securities are RSUs granted to Mr. Kiper, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Kiper holds these RSUs for the benefit of Legion Partners Asset Management. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions. As of the date hereof, 58,069 RSUs have vested.

F5 · ownership.direct: Mr. Kiper serves on the Board as a representative of Legion Partners Asset Management and its affiliates. Mr. Kiper does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position, except to the extent of his role as a Managing Director of Legion Partners Asset Management. Legion Partners Asset Management is entitled to receive all of the economic interest in securities granted to Mr. Kiper by the Issuer in respect of Mr. Kiper's Board position. Mr. Kiper disclaims beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Kiper had any economic interest in such securities except any indirect economic interest through Legion Partners Asset Management and its affiliates, entities in which Mr. Kiper has a controlling interest and investment control.

F6 · ownership.direct: The securities held by Mr. Kiper as described in footnotes (4) and (5) are securities in which Legion Partners Asset Management has all of the direct economic interest. Legion Partners Holdings is the sole member of Legion Partners Asset Management and each of Messrs. Kiper and White are Managing Directors of Legion Partners Asset Management. As a result of these relationships, Legion Partners Holdings and Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners Asset Management.

SEC source: 0002022547-26-000003 · wk-form4_1779395291.xml · nonDerivative · entry 1

Josephs Paul · CIK 0002022547 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 592,915

F1 · shares: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting.

SEC source: 0002062209-26-000004 · wk-form4_1776371972.xml · nonDerivative · entry 1

Salus Thomas D. · CIK 0002062209 · Chief Legal & Administration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,333

F1 · shares: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting.

SEC source: 0002062209-26-000002 · wk-form4_1772495559.xml · nonDerivative · entry 1

Salus Thomas D. · CIK 0002062209 · Chief Legal & Administration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,978

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Restricted Stock Units will vest on the 3rd anniversary of the grant date.

SEC source: 0001005286-25-000120 · wk-form4_1757018519.xml · nonDerivative · entry 1

Lake Ryan David · CIK 0001450325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,691

F1 · shares: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting.

SEC source: 0001005286-25-000094 · wk-form4_1752792527.xml · nonDerivative · entry 1

OBUS NELSON · CIK 0001017043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,193

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof).

SEC source: 0000921895-25-002006 · form409050032_07172025.xml · nonDerivative · entry 1

Kiper Christopher S · CIK 0001432744 · Director · 10% owner

Legion Partners Asset Management, LLC · CIK 0001560207 · Director · 10% owner

Legion Partners, L.P. I · CIK 0001595909 · Director · 10% owner

Legion Partners, L.P. II · CIK 0001618783 · Director · 10% owner

Legion Partners, LLC · CIK 0001682390 · Director · 10% owner

Legion Partners Holdings, LLC · CIK 0001682389 · Director · 10% owner

White Raymond T. · CIK 0001682494 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,575

F1 · security: This Form 4 is filed jointly by Legion Partners, L.P. I ("Legion Partners I"), Legion Partners, L.P. II ("Legion Partners II"), Legion Partners, LLC ("General Partner"), Legion Partners Asset Management, LLC ("Legion Partners Asset Management"), Legion Partners Holdings, LLC ("Legion Partners Holdings"), Christopher S. Kiper and Raymond White (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that owns more than 10% of Lifecore Biomedical, Inc.'s (the "Issuer") outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F4 · kind: These securities are RSUs granted to Mr. Kiper, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Kiper holds these RSUs for the benefit of Legion Partners Asset Management. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions. As of the date hereof, 58,069 RSUs have vested.

F5 · kind: Mr. Kiper serves on the Board as a representative of Legion Partners Asset Management and its affiliates. Mr. Kiper does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position, except to the extent of his role as a Managing Director of Legion Partners Asset Management. Legion Partners Asset Management is entitled to receive all of the economic interest in securities granted to Mr. Kiper by the Issuer in respect of Mr. Kiper's Board position. Mr. Kiper disclaims beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Kiper had any economic interest in such securities except any indirect economic interest through Legion Partners Asset Management and its affiliates, entities in which Mr. Kiper has a controlling interest and investment control.

F6 · kind: The securities held by Mr. Kiper as described in footnotes (4) and (5) are securities in which Legion Partners Asset Management has all of the direct economic interest. Legion Partners Holdings is the sole member of Legion Partners Asset Management and each of Messrs. Kiper and White are Managing Directors of Legion Partners Asset Management. As a result of these relationships, Legion Partners Holdings and Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners Asset Management.

F2 · shares: The restricted stock units ("RSUs") convert into Common Stock of the Issuer on a 1 for 1 basis.

F3 · shares: Vests on earlier of the first anniversary of the grant date or the date of the annual meeting of stockholders first held in calendar year 2026 (provided such date is no less than 50 weeks from grant date).

F2 · price: The restricted stock units ("RSUs") convert into Common Stock of the Issuer on a 1 for 1 basis.

F3 · price: Vests on earlier of the first anniversary of the grant date or the date of the annual meeting of stockholders first held in calendar year 2026 (provided such date is no less than 50 weeks from grant date).

F4 · balance_after: These securities are RSUs granted to Mr. Kiper, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Kiper holds these RSUs for the benefit of Legion Partners Asset Management. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions. As of the date hereof, 58,069 RSUs have vested.

F5 · balance_after: Mr. Kiper serves on the Board as a representative of Legion Partners Asset Management and its affiliates. Mr. Kiper does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position, except to the extent of his role as a Managing Director of Legion Partners Asset Management. Legion Partners Asset Management is entitled to receive all of the economic interest in securities granted to Mr. Kiper by the Issuer in respect of Mr. Kiper's Board position. Mr. Kiper disclaims beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Kiper had any economic interest in such securities except any indirect economic interest through Legion Partners Asset Management and its affiliates, entities in which Mr. Kiper has a controlling interest and investment control.

F6 · balance_after: The securities held by Mr. Kiper as described in footnotes (4) and (5) are securities in which Legion Partners Asset Management has all of the direct economic interest. Legion Partners Holdings is the sole member of Legion Partners Asset Management and each of Messrs. Kiper and White are Managing Directors of Legion Partners Asset Management. As a result of these relationships, Legion Partners Holdings and Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners Asset Management.

F4 · ownership.direct: These securities are RSUs granted to Mr. Kiper, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Kiper holds these RSUs for the benefit of Legion Partners Asset Management. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions. As of the date hereof, 58,069 RSUs have vested.

F5 · ownership.direct: Mr. Kiper serves on the Board as a representative of Legion Partners Asset Management and its affiliates. Mr. Kiper does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position, except to the extent of his role as a Managing Director of Legion Partners Asset Management. Legion Partners Asset Management is entitled to receive all of the economic interest in securities granted to Mr. Kiper by the Issuer in respect of Mr. Kiper's Board position. Mr. Kiper disclaims beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Kiper had any economic interest in such securities except any indirect economic interest through Legion Partners Asset Management and its affiliates, entities in which Mr. Kiper has a controlling interest and investment control.

F6 · ownership.direct: The securities held by Mr. Kiper as described in footnotes (4) and (5) are securities in which Legion Partners Asset Management has all of the direct economic interest. Legion Partners Holdings is the sole member of Legion Partners Asset Management and each of Messrs. Kiper and White are Managing Directors of Legion Partners Asset Management. As a result of these relationships, Legion Partners Holdings and Messrs. Kiper and White may be deemed to beneficially own the securities owned directly by Legion Partners Asset Management.

SEC source: 0001005286-25-000092 · wk-form4_1752785118.xml · nonDerivative · entry 1

Johnson Paul Harold · CIK 0002034858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,060

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof).

SEC source: 0001005286-25-000091 · wk-form4_1752784972.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,060

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof).

SEC source: 0001005286-25-000090 · wk-form4_1752784888.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,060

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof).

SEC source: 0001005286-25-000089 · wk-form4_1752784823.xml · nonDerivative · entry 1

Antunes Humberto Calheiros · CIK 0001800145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,060

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof).

SEC source: 0001005286-25-000088 · wk-form4_1752784730.xml · nonDerivative · entry 1

Schechter Joshua · CIK 0001336601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,173

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof).

SEC source: 0001005286-25-000087 · wk-form4_1752784568.xml · nonDerivative · entry 1

HOUDE LOVAS KATRINA · CIK 0001269294 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,412

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof).

SEC source: 0001005286-25-000080 · wk-form4_1752180336.xml · derivative · entry 3

Salus Thomas D. · CIK 0002062209 · Chief Legal & Administration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,000

Underlying: Common Stock · 37,000 shares

Expires 2030-04-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

F2 · price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

F2 · derivative.exercise_date: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

SEC source: 0001005286-25-000080 · wk-form4_1752180336.xml · nonDerivative · entry 2

Salus Thomas D. · CIK 0002062209 · Chief Legal & Administration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,978

F3 · shares: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the performance stock unit award as reported in Table I.

SEC source: 0001005286-25-000080 · wk-form4_1752180336.xml · nonDerivative · entry 1

Salus Thomas D. · CIK 0002062209 · Chief Legal & Administration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The performance-based restricted stock units vested based on the Issuer's achievement of a stock price milestone.

F2 · price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

SEC source: 0001005286-25-000079 · wk-form4_1752180146.xml · derivative · entry 3

Lake Ryan David · CIK 0001450325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 75,000 shares

Expires 2029-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

F2 · price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

F2 · derivative.exercise_date: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

SEC source: 0001005286-25-000079 · wk-form4_1752180146.xml · nonDerivative · entry 2

Lake Ryan David · CIK 0001450325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 359,623

F3 · shares: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the performance stock unit award as reported in Table I.

SEC source: 0001005286-25-000079 · wk-form4_1752180146.xml · nonDerivative · entry 1

Lake Ryan David · CIK 0001450325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,429

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The performance-based restricted stock units vested based on the Issuer's achievement of a stock price milestone.

F2 · price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

SEC source: 0001005286-25-000078 · wk-form4_1752180022.xml · derivative · entry 3

Josephs Paul · CIK 0002022547 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,350,000

Underlying: Common Stock · 150,000 shares

Expires 2029-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

F2 · price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

F2 · derivative.exercise_date: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

SEC source: 0001005286-25-000078 · wk-form4_1752180022.xml · nonDerivative · entry 2

Josephs Paul · CIK 0002022547 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 633,328

F3 · shares: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the performance stock unit award as reported in Table I.

SEC source: 0001005286-25-000078 · wk-form4_1752180022.xml · nonDerivative · entry 1

Josephs Paul · CIK 0002022547 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 688,185

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The performance-based restricted stock units vested based on the Issuer's achievement of a stock price milestone.

F2 · price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.

SEC source: 0000950170-25-078524 · ownership.xml · nonDerivative · entry 3

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 264,180

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F5 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9000 to $7.5000, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0000950170-25-078524 · ownership.xml · nonDerivative · entry 2

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 414,599

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.500 to $6.900, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0000950170-25-078524 · ownership.xml · nonDerivative · entry 1

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 1,554,103

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.7500 to $6.7800, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0001005286-25-000074 · wk-form4_1747935780.xml · nonDerivative · entry 1

Josephs Paul · CIK 0002022547 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 538,185

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with an RSU vesting.

SEC source: 0000950170-25-073196 · ownership.xml · nonDerivative · entry 1

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 1,650,240

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0000 to $7.0100, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0000950170-25-069576 · ownership.xml · nonDerivative · entry 3

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 1,662,574

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0000 to $7.1800, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0000950170-25-069576 · ownership.xml · nonDerivative · entry 2

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 1,708,272

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0000950170-25-069576 · ownership.xml · nonDerivative · entry 1

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 1,708,972

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0000 to $7.0010, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0000950170-25-066222 · ownership.xml · nonDerivative · entry 3

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 1,714,070

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F5 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0000 to $7.0700, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0000950170-25-066222 · ownership.xml · nonDerivative · entry 2

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 1,729,917

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F4 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0000 to $7.1100, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0000950170-25-066222 · ownership.xml · nonDerivative · entry 1

English Aron R. · CIK 0001770436 · 10% owner

22NW, LP · CIK 0001694297 · 10% owner

22NW Fund, LP · CIK 0001640809 · 10% owner

22NW Fund GP, LLC · CIK 0001770575 · 10% owner

22NW GP, Inc. · CIK 0001783663 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By: 22NW Fund, LP

Disclosed balance after: 1,730,618

F1 · security: This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · price: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0000 to $7.3650, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

SEC source: 0001005286-25-000070 · wk-form4_1744835921.xml · derivative · entry 4

Salus Thomas D. · CIK 0002062209 · Chief Legal & Administration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,000

Underlying: Common Stock · 210,000 shares

Expires 2032-04-14

SEC source: 0001005286-25-000070 · wk-form4_1744835921.xml · derivative · entry 3

Salus Thomas D. · CIK 0002062209 · Chief Legal & Administration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 370,000 shares

Expires 2030-04-14

F2 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · shares: Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.

F4 · derivative.exercise_date: The performance-based restricted stock units vest, if at all, based on the Issuer's achievement of certain stock prices.

F3 · derivative.underlying_shares: Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.

SEC source: 0001005286-25-000070 · wk-form4_1744835921.xml · nonDerivative · entry 2

Salus Thomas D. · CIK 0002062209 · Chief Legal & Administration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,000

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

SEC source: 0001005286-25-000070 · wk-form4_1744835921.xml · nonDerivative · entry 1

Salus Thomas D. · CIK 0002062209 · Chief Legal & Administration

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

SEC source: 0001628280-25-000943 · wk-form4_1736370610.xml · nonDerivative · entry 1

Josephs Paul · CIK 0002022547 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 559,717

SEC source: 0001628280-24-050620 · wk-form4_1733866009.xml · nonDerivative · entry 2

Josephs Paul · CIK 0002022547 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 542,717

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the stock grant.

SEC source: 0001628280-24-050620 · wk-form4_1733866009.xml · nonDerivative · entry 1

Josephs Paul · CIK 0002022547 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 554,486

SEC source: 0001628280-24-050619 · wk-form4_1733865968.xml · nonDerivative · entry 2

Lake Ryan David · CIK 0001450325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,429

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the stock grant.

SEC source: 0001628280-24-050619 · wk-form4_1733865968.xml · nonDerivative · entry 1

Lake Ryan David · CIK 0001450325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,082

SEC source: 0001628280-24-044118 · wk-form4_1730234796.xml · nonDerivative · entry 2

Lake Ryan David · CIK 0001450325 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,362